Published online Oct 26, 2022. doi: 10.4330/wjc.v14.i10.546
Peer-review started: July 2, 2022
First decision: August 1, 2022
Revised: August 27, 2022
Accepted: September 15, 2022
Article in press: September 15, 2022
Published online: October 26, 2022
Processing time: 109 Days and 4.4 Hours
Haemophilus parainfluenzae (HPI) belongs to the HACEK (Haemophilus spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella spp., and Kingella spp.) group of organisms. The HACEK group of organisms are a part of the oropharyngeal flora and can cause invasive opportunistic infection such infective endocarditis (IE) in hosts with compromised immunological barriers.
To perform a 20-year systematic review of the literature characterizing the clinical presentation, epidemiology and prognosis of HPI IE.
We performed a systematic review of Medline, Pubmed, Scopus and Embase from 2000 to 2022 to identify all cases of HPI IE.
Thirty-nine adult cases were identified. HPI IE was found to affect males slightly more than females and is common in patients with predisposing risk factors such as underlying valvular abnormalities. It mostly affected the mitral valve and had an indolent course; significantly sized vegetations (> 1 cm) developed in most cases. Central nervous system septic embolization was common. It had a favo
Clinicians should be attentive to the indolent course of HPI IE and the presence of predisposing risk factors in order to allow for timely management.
Core tip: This review and illustrative case show a temporal change in the epidemiology of Haemophilus parainfluenzae (HPI) infective endocarditis in 2000–2022. Compared with a review of 26 HPI endocarditis cases from 1984–1995 by Darras-Joly et al, this review reported younger mean age, similar rate of infection in both genders, shorter time to diagnosis, higher association with intravenous drug use (IVDU), higher rate of embolic events in general, and tricuspid and pulmonic valve involvement. The rate of mitral valve involvement has remained steady over the past three decades, while there has been a decrease in the rate of aortic valve involvement. There has been a decrease in valvular vegetation rates and incidence of congestive heart failure as complications, while the mortality rate remained similar. These findings indicate improvement in diagnosis and treatment of HPI over the past three decades; however, they also suggest an increase in its virulence and an association with the rising rate of IVDU highlighted by the involvement of the right-sided heart valves.